An average of 9.5% of American adults ages 18 and over will suffer from an ongoing depressive illness every year – that’s roughly 17 million people. For many, finding relief is a daily struggle between managing symptoms, avoiding triggers, and trying to find a treatment plan that actually works – the latter often proving to … Continue reading Cannabichromene – How CBC Interacts With Our Brain’s “Bliss” Molecule to Target Depression